News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Novel Therapeutics Forum Brings Together Investors and Innovators at Penn
PCI and Penn Medicine partnered with Citizens JMP for the inaugural ‘Novel Therapeutics Forum’ at Penn.
ToxiSense Develops Plant-Based Alternativeto Horseshoe Crab Blood
ToxiSense is developing a plant-based alternative to test for bacterial toxins in vaccines and medical devices, which could eliminate the current need for bloodletting of horseshoe crabs.
Linnaeus Therapeutics Awarded European Patent
Linnaeus Therapeutics, Inc. announced the issuance of EP patent 3823617 by the European Patent Office (EPO) covering the pharmaceutical composition of matter for their lead compound, LNS8801.
Exyn Technologies Pioneers Drone Software for GPS-denied Environments
Exyn Technologies, a PCI Ventures portfolio company focused on multi-platform robotic autonomy, is receiving global recognition for its groundbreaking drone software.
Nia Therapeutics Raises $8.5 Million
Penn spinout Nia Therapeutics recently raised $8.5 million in an equity financing round.
2024 President’s Innovation Prize Winning Team Focused on Making Life Easier for Students with Learning Differences
The President's Innovation Prize was recently awarded to fourth year Penn Engineering students for their project Jochi.
Capstan raises $175M Series B
Proceeds from the financing will be used to advance Capstan's lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, CPTX2309, to early clinical proof-of-concept in autoimmune disorders.
iEcure Gains FDA approval to Conduct FirstGene Therapy Treatment
Utilizing ARCUS, a gene editing tool developed by Precision BioSciences, the therapy aims to provide a lifelong fix for this disease, potentially benefiting thousands of individuals in the US alone.
Penn Provides Expert Testimony for State Senate Policy Committee Public Hearing on Pennsylvania as an Innovation Leader
The Senate Republican Policy Committee convened a public hearing exploring Pennsylvania’s role as an innovation hub and the importance of startups and established companies.
Penn Researchers Discover New Technique to Form Human Artificial Chromosomes
Researchers at Penn led by Ben Black, PhD, the Eldridge Reeves Johnson Foundation Professor of Biochemistry and Biophysics, have found a new way to create synthetic chromosomes.